Heterogeneous macrophages: Supersensors of exogenous inducing factors.
- Published in:
- Scandinavian Journal of Immunology, 2019, v. 90, n. 1, p. 1, doi. 10.1111/sji.12768
- By:
- Publication type:
- Article
Works by Yun, Zehui
Results: 4
1
2
Endocrine therapy plus HER2-targeted therapy, another favorable option for HR+/HER2+ advanced breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231220501
- By:
- Publication type:
- Article
3
HER2 status results in an unstable switch from primary to recurrent breast cancer.
- Published in:
- Neoplasma, 2024, v. 71, n. 4, p. 392, doi. 10.4149/neo_2024_240229N89
- By:
- Publication type:
- Article
4
Using dynamic cell communication improves treatment strategies of breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review